AI assistant
PROTHENA CORP PUBLIC LTD CO — Director's Dealing 2016
Feb 26, 2016
32782_dirs_2016-02-26_69a608b2-9522-4d03-af2f-495cc247f82c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Prothena Corp plc (PRTA)
CIK: 0001559053
Period of Report: 2016-02-24
Reporting Person: Schenk Dale B. (Director, President and CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-02-24 | Stock Option (right to buy) | $34.61 | A | 200000 | Acquired | 2026-02-24 | Ordinary Shares (200000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares, par value $0.01 per share | 14877 | Indirect |
Footnotes
F1: The shares are held by the Schenk Family Trust, dated 2/9/2004, of which Reporting Person is a Co Trustee with his spouse.
F2: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 24, 2017 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.